Aap Implantate AG
AAQ1
Rank in Stocks
#25992
Operating as a medical technology firm, aap Implantate AG specializes in the... Operating as a medical technology firm, aap Implantate AG specializes in the development, manufacturing, and commercialization of orthopedic trauma devices. The company's market presence spans Germany, the United States, and various international regions. Its primary offerings feature LOQTEQ, an advanced anatomical plating system crucial for fracture treatment, in addition to a diverse selection of cannulated screws, conventional plates, and standard screws. Products are distributed under the 'aap' brand, reaching customers directly, including hospitals, purchasing syndicates, and hospital groups, as well as indirectly via its network of distributors. aap Implantate AG was founded in 1990 and maintains its corporate headquarters in Berlin, Germany.
Share Price
$1.56
Last synced: 2026-11-11
Market Cap
$22.58M
Change (1 day)
0.95%
Change (1 year)
-7.35%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Aap Implantate AG (AAQ1)
Category
Healthcare
Operating Margin for Aap Implantate AG (AAQ1)
Operating Margin as of November 2026 TTM: 33.72%
According to Aap Implantate AG's latest financial reports, its current operating margin (TTM) is 33.72%. At the end of 2025 the company had an operating margin of -20.00%.
Operating Margin history for Aap Implantate AG from 2002 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 33.72% | -268.60% |
| 2025 | -20.00% | -10.19% |
| 2024 | -22.27% | -50.54% |
| 2023 | -45.03% | 53.06% |
| 2022 | -29.42% | -9.20% |
| 2021 | -32.40% | -63.78% |
| 2020 | -89.46% | 9.18% |
| 2019 | -81.94% | 8.63% |
| 2018 | -75.43% | 2.86% |
| 2017 | -73.33% | -24.48% |
| 2016 | -97.10% | 37.01% |
| 2015 | -70.87% | -16,581.40% |
| 2014 | 0.43% | -83.46% |
| 2013 | 2.60% | -43.11% |
| 2012 | 4.57% | 14.54% |
| 2011 | 3.99% | 57.71% |
| 2010 | 2.53% | -76.75% |
| 2009 | 10.88% | -174.83% |
| 2008 | -14.54% | -237.82% |
| 2007 | 10.55% | -8.74% |
| 2006 | 11.56% | 489.80% |
| 2005 | 1.96% | -67.55% |
| 2004 | 6.04% | -264.58% |
| 2003 | -3.67% | -110.97% |
| 2002 | 33.44% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 18.91% | -99.44% |
IE
|
|
| 10.95% | -99.68% |
CN
|
|
| 25.26% | -99.25% |
CH
|
|
| 13.54% | -99.60% |
CH
|
|
| 38.62% | -98.85% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Aap Implantate AG's operating margin
What is Aap Implantate AG's operating margin?
Aap Implantate AG's operating margin is 33.72%, as of Nov 2026.
What was Aap Implantate AG's operating margin in 2025?
In 2025, Aap Implantate AG's operating margin was -20.00%, compared with -22.27% in 2024.
How has Aap Implantate AG's operating margin changed since 2020?
From 2020 to 2025, Aap Implantate AG's operating margin was highest in 2025 (-20.00%) and lowest in 2020 (-89.46%).
How does Aap Implantate AG's operating margin compare with similar companies?
Aap Implantate AG's operating margin (33.72%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Jafron Biomedical Co.,Ltd., with 38.62%.